Mandate

Anhui Shanying Paper acquires Nordic Paper

August 02, 2017

Vinge has advised Anhui Shanying Paper Industry Co., LTD (“Anhui Shanying Paper”) in conjunction with its acquisition of Nordic Paper Holding AB (”Nordic Paper”) from Holding Blanc Bleu 5 S.à r.l, (controlled by funds which are advised by Orlando Management AG) and Petek GmbH.

Anhui Shanying Paper, which is part of the Taison Group, is a China-based pulp and papermill company which has been listed on the Shanghai stock exchange since 2001. Nordic Paper is a leading supplier of paper within the kraft paper and the greaseproof paper segments. Nordic Paper currently has four paper facilities in Bäckhammar, Åmotfors, Säffle in Sweden as well as Greåker in Norway and delivers paper to customers in more than 80 countries. The acquisition is conditional upon customary conditions to closing.

Vinge’s team has consisted of, among others, partners Jonas Bergström, Johan Larsson, senior counsel Gu Qun, associate Samra Baytar, counsel Joacim Rydergård, associates Pål Walhammar och Lisa Sennerby (M&A), counsel Johan Cederblad (Environmental), associates Lova Unge (Employment), Frida Ställborn (Real Estate), Josefine Lanker (Financial Arrangements), Victor Wahlqvist and Victor Berg (Commercial Agreements) and Parul Sharma (CSR and Compliance) and partner Pär Remnelid and associate Nils Alvång (EU, Competition & Regulatory)
 

Related

Vinge has advised Verisure in connection with its IPO on Nasdaq Stockholm

Vinge has advised Verisure plc (“Verisure”) in connection with its IPO on Nasdaq Stockholm. Following the publication of the prospectus on 29 September 2025, trading in Verisure’s shares commenced today, 8 October 2025.
October 08, 2025

Vinge has acted for Advania on the acquisition of smartvokat

smartvokat GmbH, a German-based consultancy specialising in digital transformation within the legal, risk, and compliance domains, will become part of Advania’s business unit Transformation & Automation.
October 08, 2025

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025